Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

Attia, Peter, Phan, Giao Q., Maker, Ajay V., Robinson, Michael R., Quezado, Martha M., Yang, James C., Sherry, Richard M., Topalian, Suzanne L., Kammula, Udai S., Royal, Richard E., Restifo, Nicholas P., Haworth, Leah R., Levy, Catherine, Mavroukakis, Sharon A., Nichol, Geoff, Yellin, Michael J., Rosenberg, Steven A.·2005·Journal of Clinical Oncology
DOI 10.1200/jco.2005.06.205

Cited by (1,000)

Items 901–1,000 of 1,000

  1. Chemoprevention of Familial Melanoma
    Vidhya Hariharan · 2011 · Loyola eCommons (Loyola University of Chicago)
  2. Ipilimumab: report and comment about the MDX010-020 clinical trial
    Stefania Vittoria Luisa Nicoletti, Francesco De Rosa, Ruggero Ridolfi · 2012 · Expert Review of Dermatology
  3. Cancer immunotherapeutics: raising the ante.
    Mangesh A. Thorat, Ram H. Datar, Narendra N. Joshi · 2006 · PubMed
  4. Anti-CTLA-4 Monoclonal Antibodies
    Arvin S. Yang, Jedd D. Wolchok · 2011 · Springer eBooks
  5. Review Article Regulatory T-cells in chronic lymphocytic leukemia: actor or innocent bystander?
    Giovanni Francesco D'Arena, Vittorio Simeon, Teodora Statuto, Pierangelo Di Sanzo, Laura De Martino, Aurelio Marandino, Michele Sangiorgio, Pellegrino Musto, Vincenzo De Feo · 2013
  6. GENERATION OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FROM PERIPHERAL BLOOD OF COLORECTAL CANCER PATIENTS FOR ADOPTIVE T-CELL TRANSFER
    Medicina Molecolare · 2013
  7. Lang anhaltendes Ansprechen auf die Behandlung mit Ipilimumab: Ein Argument gegen die Erhaltungstherapie?
    Julika Dick, Alexander Enk, Jessica C. Hassel · 2015 · Kompass Onkologie
  8. Verzögert auftretende Paraplegie nach Vollremission unter 2 Zyklen Ipilimumab bei metastasiertem Melanom
    Grainne Mary O'Kane, Tomás G. Lyons, Gabrielle Colleran, Marzuki Wan Ahmad, Scheryll Paula Alken, Eoin Carl Kavanagh, David A. Fitzpatrick, Brian Murray, Catherine Margaret Kelly · 2015 · Kompass Dermatologie
  9. Immunomodulation in Dermatology
    Rebecca G. Pomerantz, Thomas Seth Kupper, Abrar A. Qureshi · 2010 · Springer eBooks
  10. Regulatory T Cells and Tumour Immunotherapy
    Ilona Kryczek, Weiping Zou · 2008 · Springer eBooks
  11. Enhancing anti-tumor immunity to MHC class I-deficient tumors: role of regulatory T cells and type I IFN
    Ioanna E. Galani · 2008 · heiDOK (Heidelberg University)
  12. Autoimmune hypophysitis in a patient successfully treated with anti-ctla-4 (Ipilimumab) immunotherapy for metastatic malignant melanoma
    R.A. Sutton, Mark Voskoboynik, Grant A. McArthur, Julie Lokan · 2013 · Pathology
  13. Progress in the management of metastatic melanoma
    Steven J O'Day · 2011 · Community Oncology
  14. Incidence of lung pathology in the dissecting room: a valuable teaching asset
    Wee Ming Soh, Harold Ellis · 2013 · Pathology
  15. ANTICUERPOS MONOCLONALES EN EL TRATAMIENTO DEL CÁNCER. TERAPIA DIRIGIDA PARA TUMORES SÓLIDOS
    Jaheli Fuenmayor, Ricardo Gamez Hoyos, Ramón F. Montaño · 2013 · Redalyc (Universidad Autónoma del Estado de México)
  16. Introduction
    Van Anh Trinh, Jamie Poust · 2008 · American Journal of Health-System Pharmacy
  17. Immune-Related Response Criteria and Guidance for Clinical Trials
    Hiroyuki Y. Suzuki · 2016 · Springer eBooks
  18. REVISIONES El potencial de la inmunomodulación con anticuerpos monoclonales anti-CD137 (4-1BB) para terapia de enfermedades malignas e infecciones virales crónicas The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases
    Carlos Alfaro, Oihana Murillo, Iñigo Tirapu, Arantza Azpilicueta, Eduardo Huarte, Ainhoa Arina, Laura Arribillaga, Maurizio Bendandi, Jesús Prìeto, Juan José Lasarte et al. · 2006
  19. Targeting Oncoproteins for Molecular Cancer Therapy
    Joshua E. Allen, Wafik S. El‐Deiry · 2016 · Springer eBooks
  20. Current Treatment Modalities in Advanced Melanoma
    Hilayda Karakök Güngör, Bengü Nisa Akay · 2016 · Turkish Journal of Dermatology
  21. Immune Checkpoint Inhibitors in Melanoma Define a New Era in Immunotherapy Aiming for Cure
    Alexander M.M. Eggermont, Dirk Schadendorf, Caroline Robert · 2017 · Springer eBooks
  22. Cancer bronchique non à petites cellules de stade IV sans addiction oncogénique : traitements en 2e ligne et au-delà
    Clément Gauvain, Alexis Benjamin Cortot · 2017 · Revue des Maladies Respiratoires Actualités
  23. Measuring Markers of Immune Response in Patients Treated with Nivolumab (Opdivo®) and Pembrolizumab (Keytruda®)
    Leah Butt · 2017 · Otago University Research Archive (University of Otago)
  24. State of the Science
    Sanjiv S. Agarwala · 2007 · Oncology Issues
  25. The Role of HDAC6 and HDAC11 in Shaping Anti-Tumor Responses – Insights into Epigenetic Regulation of Tumor and T-Cell Immunobiology
    Karrune V. Woan · 2012 · University of Florida Digital Collections (University of Florida)
  26. Toxicité pulmonaire de l’immunothérapie par les inhibiteurs de point de contrôle
    Marjolaine Georges · 2017 · Revue des Maladies Respiratoires Actualités
  27. Necrólise epidérmica tóxica associada ao uso de nivolumabe: um relato de caso
    Sandro Laércio Reichow, Carini Dagnoni, Amanda Maieski · 2017 · Brazilian Journal of Oncology
  28. Monoclonal Antibodies
    Caroline Robert · 2013
  29. Ocular Complications of Targeted Therapy
    Ashley E. Neiweem, Denis Jusufbegovic, Arun D. Singh · 2019 · Springer eBooks
  30. Tumor-induced immune suppression of therapeutic cancer vaccines
    Joseph E. Burgents · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  31. Secondary hypophysitis due to immune checkpoint inhibitors – case report and literature review
    UMF Carol Davila Bucharest, Romania, Iuliana Ilie, AIlin Septar, Dan Hortopan, A Caragheorgheopol, Carmen Nicoleta Iordachescu, Florin Alexiu, Viviana Elian, Andreea Banica, Luciana Oprea et al. · 2019 · ROMANIAN BIOTECHNOLOGICAL LETTERS
  32. Human Antibodies from Transgenic Mice
    Nils Lönberg · 2009 · Wiley eBooks
  33. Recent Insights Into In Utero Gene Editing, Checkpoint Inhibitors, and Polymorphonuclear Extracellular Vesicles
    Aoife O’Reilly, Abhilash Sahadevan, Waheed Shah, Michael P. Keane, Cormac McCarthy · 2020 · American Journal of Respiratory Cell and Molecular Biology
  34. Non-melanoma Skin Cancer and Cutaneous Melanoma from the Oncological Point of View
    Helen J Gogas, Panagiotis Theodorou Diamantopoulos, Aristidis Polyzos · 2020 · Springer eBooks
  35. Infections of the Oesophagus and Rare Forms of Oesophagitis
    Shaun V Walsh · 2020 · Cambridge University Press eBooks
  36. The Value of Gastrointestinal Biopsy
    Constantinos A. Parisinos, Vinay Sehgal, Gareth C. Parkes · 2020 · Cambridge University Press eBooks
  37. Complications of Inflammatory Bowel Disease
    Roger M. Feakins · 2020 · Cambridge University Press eBooks
  38. Transplantation, Immunodeficiency, and Immunosuppression
    Newton A C S Wong · 2020 · Cambridge University Press eBooks
  39. Radiation and the Gastrointestinal Tract
    Roger M. Feakins · 2020 · Cambridge University Press eBooks
  40. Assessment of Gastric Biopsies
    Tim Andrews, Fiona Campbell · 2020 · Cambridge University Press eBooks
  41. Gastrointestinal Involvement by Systemic Disease
    Adrian Calvin Bateman · 2020 · Cambridge University Press eBooks
  42. Ileal Pouch Anal Anastomosis
    Shaun V. Walsh, Roger M. Feakins · 2020 · Cambridge University Press eBooks
  43. Normal Oesophageal, Gastric and Duodenal Mucosa
    Roger M. Feakins · 2020 · Cambridge University Press eBooks
  44. Inflammatory Bowel Disease and the Upper Gastrointestinal Tract
    Roger M. Feakins · 2020 · Cambridge University Press eBooks
  45. Normal Lower Gastrointestinal Mucosa
    Roger M. Feakins · 2020 · Cambridge University Press eBooks
  46. Jejunitis and Ileitis
    Karel Geboes, Anne Jouret‐Mourin · 2020 · Cambridge University Press eBooks
  47. Non-Neoplastic Diseases of the Anal Canal
    Morgan Moorghen · 2020 · Cambridge University Press eBooks
  48. Types of Gastritis
    Tim Andrews, Fiona Campbell · 2020 · Cambridge University Press eBooks
  49. Cancer and the Cellular Immune Response
    Yong-Jun Liu, Patrick Hwu · 2008 · Elsevier eBooks
  50. Novel biomarkers for melanoma immunotherapy
    Ngai Man Annie Wong · 2020 · Minerva Access (University of Melbourne)
  51. Endocrinopathies Associated With Immune Checkpoint Inhibitors
    Monica Girotra · 2021 · Elsevier eBooks
  52. Practical Management of Melanoma
    Mark F. Naylor · 2009 · Springer eBooks
  53. Checkpoint Blockade and Combinatorial Immunotherapies
    Karl S. Peggs, Sergio A. Quezada, James Patrick Allison · 2007 · Springer eBooks
  54. Cancer Immunotherapy
    Padmanee Sharma, Sumit Kumar Subudhi, Karl S. Peggs, Sangeeta Goswami, Jianjun Gao, Sergio A. Quezada, James Patrick Allison · 2017 · Wiley eBooks
  55. Altered Signal Transduction Pathways in Melanoma
    Yann Chéli, Eric K. Lau, Ze’ev A. Ronai · 2017 · Springer eBooks
  56. Immunology of Cancer
    Craig Lee Slingluff · 2008 · Springer eBooks
  57. Immunobiology and Immune Based Therapies of Melanoma
    David L. Chen, Cheryl A. Armstrong, Mariah Ruth Brown · 2017 · Springer eBooks
  58. Frontiers in Cancer Immunotherapy
    Joseph F. Murphy · 2020 · Springer eBooks
  59. Coeliac Disease
    Colan Ho-Yen, Fuju Chang · 2020 · Cambridge University Press eBooks
  60. Preface
    Roger M. Feakins · 2020 · Cambridge University Press eBooks
  61. DNA Vaccines Against Cancer
    Adam D. Cohen, Jedd D. Wolchok · 2007 · Springer eBooks
  62. Duodenitis
    Lindsey Clarke, Roger M. Feakins · 2020 · Cambridge University Press eBooks
  63. Immunotoxicology of Biopharmaceutics☆
    Helen G. Haggerty, Karen Price, Jacintha M. Shenton · 2014 · Elsevier eBooks
  64. Cancer Vaccines
    Daniel A. Laheru · 2010 · Springer eBooks
  65. CTLA-4
    Tasha Hughes, Howard L. Kaufman · 2013 · Springer eBooks
  66. Overcoming Cancer Tolerance with Immune Checkpoint Blockade
    John William Myers, George Earl Peoples, Guy Travis Clifton · 2020 · Springer eBooks
  67. Author reply
    Steven Yeh, Steven A. Rosenberg, Robert Burton Nussenblatt · 2010 · Ophthalmology
  68. Scalp Tumors
    Ciara D. Harraher, John A. Persing, Elizabeth B. Claus · 2011 · Elsevier eBooks
  69. Management of Dysplastic Nevi and Melanomas
    Ashfaq A. Marghoob, Ivanka Kovalyshyn, Allan C. Halpern · 2010 · Elsevier eBooks
  70. Melanoma
    Julie R. Lange, Leslie Anne Fecher, William Howard Sharfman, Rhoda M. Alani, Radha Mikkilineni, Suzanne Louise Topalian, Charles M. Balch · 2008 · Elsevier eBooks
  71. Autoimmunity and Prognosis in Cancer
    Theresa L. Whiteside · 2008 · Springer eBooks
  72. CTLA-4
    Tasha M. Hughes, Howard L. Kaufman · 2017 · Springer eBooks
  73. Tumor Vaccines for Breast Cancer
    Karen S. Anderson · 2007 · Translational medicine series
  74. Autoimmunity and Cancer
    Theresa L. Whiteside · 2015 · Springer eBooks
  75. Index
    Roger M. Feakins · 2020 · Cambridge University Press eBooks
  76. Autoimmunity and Prognosis in Cancer
    Theresa L. Whiteside · 2011 · Springer eBooks
  77. Regulatory T Cells - New Insights
    Xuehui He · 2022 · IntechOpen eBooks
  78. Investigation of CTLA4’s Application in Advanced Melanoma with Ipilimumab and Nivolumab
    Winnie Xiong · 2022 · Highlights in Science Engineering and Technology
  79. Malignant Melanoma
    Michael J. Carr, Justin Ko, Susan M. Swetter, Scott Eric Woodman, Vernon K. Sondak, Kim Allyson Margolin, Jonathan S. Zager · 2022 · Wiley eBooks
  80. The Rise in Immunotherapy and Associated Ocular Toxicities
    Anam A. Mazharuddin, Dan S. Gombos, Nagham S Al-Zubidi · 2022 · Springer eBooks
  81. Endocrine Consequences Following Immune Checkpoint Inhibitors Therapy
    Aikaterini Lavrentaki, Georgia Ntali · 2023 · Springer eBooks
  82. Data from A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients
    Nancy J. Nesslinger, Alvin Wei Tian Ng, Kwong-Yok Tsang, Theresa A. Ferrara, Jeffrey Schlom, James L. Gulley, Brad H. Nelson · 2023
  83. Data from A Viral Vaccine Encoding Prostate-Specific Antigen Induces Antigen Spreading to a Common Set of Self-Proteins in Prostate Cancer Patients
    Nancy J. Nesslinger, Alvin Wei Tian Ng, Kwong-Yok Tsang, Theresa A. Ferrara, Jeffrey Schlom, James L. Gulley, Brad H. Nelson · 2023
  84. Supplementary Figure 3 from Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab
    Alexander Martens, Kilian Wistuba‐Hamprecht, Jianda D. Yuan, Michael Andrew Postow, Phillip Wong, Mariaelena Capone, Gabriele Madonna, Amir Khammari, Bastian Schilling, Antje Sucker et al. · 2023
  85. Malignant Melanoma
    Justin Ko, Susan M. Swetter, Jonathan S. Zager, Vernon K. Sondak, Scott Eric Woodman, Kim Allyson Margolin · 2017 · Wiley eBooks
  86. Immunotherapy for Melanoma
    Eirini Pectasides, Helen J Gogas · 2023 · Springer eBooks
  87. Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas
    Evan Rosenbaum P. E, Kenneth P. Seier, Martina Bradić, Ciara Marie Kelly, Sujana Movva, Benjamin Alexander Nacev, Mrinal M. Gounder, Mary Louise Keohan, Viswatej Avutu, Ping Chi et al. · 2023
  88. Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas
    Evan Rosenbaum P. E, Kenneth P. Seier, Martina Bradić, Ciara Marie Kelly, Sujana Movva, Benjamin Alexander Nacev, Mrinal M. Gounder, Mary Louise Keohan, Viswatej Avutu, Ping Chi et al. · 2023
  89. Vaccine-induced effects on regulatory T cell function: autoimmune perspective
    Alexander Batista-Duharte · 2024 · Elsevier eBooks
  90. Biomarkers for response to immune checkpoint inhibitors in metastatic melanoma
    Thijs T. Wind · 2024 · University of Groningen research database (University of Groningen / Centre for Information Technology)
  91. Ocular Complications of Targeted Therapy
    Lucas W. Rowe, Denis Jusufbegovic, Arun D. Singh · 2024 · Springer eBooks
  92. Adoptive T-Cell Therapy in Melanoma
    Robert Connor Chick, Joal D. Beane, Carlo M. Contreras · 2025 · Surgical Oncology Clinics of North America
  93. A rapid ecologic analysis, confirmed by a case–control study, identifies class I HLA alleles correlated to the risk of COVID-19
    Pierpaolo Correale, Giovanni Baglìo, Roberto Parrella, Rita Emilena Saladino, Nunzia Cuomo, Francesco Scarano, Marina Francone, Maria Cuzzola, Giuseppe Foti, Luciano Mutti et al. · 2025 · Journal of Translational Medicine
  94. Management of gastrointestinal adverse effects of cancer treatment part 2: Nausea, vomiting, immune-related gastrointestinal adverse effects
    Jan Juřica, Miroslav Turjap · 2025 · Česká a slovenská farmacie
  95. Combination of Pre-existing and New Strategies to Improve CAR-T Cells’ Efficiency
    Lakshya Tanwar · 2025 · International journal of high school research
  96. Characterization of a Phage Display-Selected scFv Against Neuropilin 1 (NRP1) Isolated from a Naïve Human Library
    Khadijeh Farrokhi, Fatemeh Nasiri, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani · 2025 · Molecular Biotechnology
  97. Endocrine Consequences Following Immune Checkpoint Inhibitors Therapy
    Aikaterini Lavrentaki, Georgia Ntali · 2025 · Springer eBooks
  98. Immunotoxicology of Biopharmaceutics
    Helen G. Haggerty, Karen Price, Jacintha M. Shenton · 2018 · Elsevier eBooks
  99. Nebenwirkungen von Immuntherapien
    Fabian Bauer, Thorsten Persigehl · 2025 · Die Radiologie
  100. Extending the Use of Adoptive T Cell Immunotherapy for Infections and Cancer
    Ulrike Gerdemann, Malcolm K. Brenner · 2010 · Humana Press eBooks